TherapeuticsMD (TXMD) Operating Income Growth (1y) (2012 - 2026)
TherapeuticsMD (TXMD) Operating Income Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn | 25.63% |
| 3 | Zoetis | 32.67 Bn | 30.73 Bn | 1.62 Bn | -1.30% |
| 4 | Takeda Pharmaceutical | 27.69 Bn | 23.63 Bn | 4.39 Bn | -319.32% |
| 5 | United Therapeutics | 23.12 Bn | 20.97 Bn | 648.10 Mn | -14.89% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.24 Bn | 18.44 Bn | 1.16 Bn | 97.23% |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn | 719.49% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.22 Bn | 785.00 Mn | 21.25% |
| 10 | TherapeuticsMD | 278,799.99 | -8.14 Mn | - | 43.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.56% |
| Dec 31, 2025 | -138.04% |
| Sep 30, 2025 | 23.99% |
| Jun 30, 2025 | 75.08% |
| Mar 31, 2025 | -12.17% |
| Dec 31, 2024 | 59.53% |
| Sep 30, 2024 | 36.04% |
| Jun 30, 2024 | -12.82% |
| Mar 31, 2024 | 57.18% |
| Dec 31, 2023 | -103.33% |
| Sep 30, 2023 | 87.79% |
| Jun 30, 2023 | 83.36% |
| Mar 31, 2023 | 85.08% |
| Dec 31, 2022 | 236.87% |
| Sep 30, 2022 | 63.63% |
| Jun 30, 2022 | 57.77% |
| Mar 31, 2022 | 38.95% |
| Dec 31, 2021 | -2.27% |
| Sep 30, 2021 | -59.85% |
| Jun 30, 2021 | 21.89% |